newsfilter
← Latest News
PR Newswire·

Mereo BioPharma Group plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights - MREO

  • The Gross Law Firm issued a securities class action notice for Mereo BioPharma Group plc (NASDAQ: MREO) shareholders.
  • The class period covers purchases made between June 5, 2023, & December 26, 2025.
  • Allegations state defendants concealed material adverse facts regarding Phase 3 ORBIT & COSMIC programs failing to hit primary endpoints for reducing annualized clinical fracture rates.
  • On December 29, 2025, Mereo announced both studies lacked statistical significance despite improved bone mineral density.
  • Mereo's ADS price dropped from $2.31 to $0.29 following the announcement, representing an 87.7% decline.
  • The deadline to register & seek appointment as lead plaintiff is April 6, 2026.
  • Participation in the case carries no cost or obligation for shareholders.